ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
식용 백신 시장 규모는 최근, 현저한 성장을 보이고 있습니다. 2025년 95억 1,000만 달러에서 2026년에는 103억 5,000만 달러로, CAGR 8.8%로 확대할 전망입니다. 지난 수년간의 성장은 유전공학 기술의 발전, 백신용 형질전환 식물에 대한 초기 조사, 공중보건 예방접종 프로그램의 확대, 대체 백신 플랫폼에 대한 자금 증가, 초기 임상 검증 연구 등에 기인하는 것으로 보입니다.
식용 백신 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 145억 4,000만 달러에 달하며, CAGR은 8.9%에 달할 전망입니다. 예측 기간 중 성장 요인으로는 바늘 없는 백신 접종 솔루션에 대한 수요 증가, 식품 백신 임상시험에 대한 투자 확대, 가축 예방접종 프로그램 확대, 세계 백신 접근성에 대한 관심 증가, 규제 승인 절차의 발전 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 식물 유래 백신 발현 시스템의 발전, 식품 백신 투여법에 대한 관심 증가, 저비용 백신 생산 모델 확대, 내열성 백신에 대한 연구 증가, 생명공학 분야와 농업 분야의 연계 강화 등을 들 수 있습니다.
감염병의 확산은 향후 식품백신 시장의 성장을 촉진할 것으로 예측됩니다. 감염은 세균, 바이러스, 곰팡이, 기생충 등 유해한 미생물이 체내로 들어와 증식하여 발생하는 질환입니다. 이러한 질병의 발생률 증가는 주로 세계화, 기후 변화, 도시화, 항생제 내성 확대 등의 요인으로 인해 새로운 병원균의 확산과 출현에 기여하고 있습니다. 식품백신은 항원을 발현하는 유전자변형식품의 섭취를 통해 면역반응을 유도하여 감염성 질환에 대응하며, 주사바늘이 필요 없는 비용효율적인 예방접종 접근법을 제공합니다. 예를 들어 미국 질병예방통제센터(CDC)의 보고에 따르면 2024년 3월 기준 결핵 환자 수는 2022년 8,320명에서 2023년 9,615명으로 1,295명이 증가할 것으로 예상하고 있습니다. 또한 인구 10만 명당 발생률은 2022년 2.5명에서 2023년 2.9명으로 상승했습니다. 따라서 감염병의 확산이 식품백신 시장의 확대를 견인하고 있습니다.
연구개발 자금 증가도 향후 식품백신 시장의 성장을 가속할 것으로 예측됩니다. R&D 자금은 새로운 지식의 창출과 혁신적인 기술 및 제품 개발을 위한 체계적인 연구 및 실험 활동에 투입되는 재정적 투자를 의미합니다. 세계 각국 정부는 세계 보건 과제에 대응하고 생명공학 분야의 경쟁력을 유지하기 위해 과학적 혁신이 중요하다는 것을 인식하고 연구개발에 대한 투자를 확대하고 있습니다. 연구 자금 증가로 연구자와 제약회사는 식품 백신 개발, 임상시험 실시, 생산 공정의 확장을 추진할 수 있습니다. 예를 들어 영국 통계청(ONS)의 2024년 12월 발표에 따르면 영국 기업은 2023년 연구개발에 647억 3,000만 달러(500억 파운드)를 지출한 것으로 나타났습니다. 이는 2022년 대비 2.9%(18억 3,000만 달러/14억 파운드) 증가한 수치입니다. 따라서 연구개발에 대한 투자 증가가 식품백신 시장 성장에 기여하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
An edible vaccine is a type of vaccine developed in genetically modified plants or animals, designed to be delivered through consumption rather than injection. These vaccines stimulate an immune response when an edible plant or food, such as fruits or vegetables, is consumed. This concept aims to provide a cost-effective and easily accessible alternative to traditional vaccines, particularly in developing countries.
The primary types of edible vaccines include inactivated vaccines, subunit vaccines, deoxyribonucleic acid (DNA) vaccines, live attenuated vaccines, and others. Inactivated vaccines are made from viruses or bacteria that have been killed or inactivated so they cannot cause disease, yet still elicit an immune response, such as the polio and hepatitis A vaccines. Distribution channels for these vaccines encompass hospitals, veterinary clinics, retail pharmacies, and online pharmacies. Their applications span medical care, livestock, aquaculture, agriculture, and more. Edible vaccines are utilized by a diverse range of end users, including adults, pediatric populations, and animals.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Tariffs are impacting the edible vaccine market by increasing costs of imported laboratory equipment, genetic engineering tools, bioprocessing reagents, and cold-chain related technologies used in vaccine development. Research institutions and biotech firms in North America and Europe are most affected due to reliance on specialized imported inputs, while emerging markets face higher R&D costs. These tariffs are slowing research timelines and increasing development expenses. However, they are also encouraging domestic biotechnology manufacturing, regional research collaborations, and localized production of vaccine development tools.
The edible vaccine market research report is one of a series of new reports from The Business Research Company that provides edible vaccine market statistics, including edible vaccine industry global market size, regional shares, competitors with a edible vaccine market share, detailed edible vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the edible vaccine industry. This edible vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The edible vaccine market size has grown strongly in recent years. It will grow from $9.51 billion in 2025 to $10.35 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to progress in genetic engineering techniques, early research in transgenic plants for vaccines, expansion of public health immunization programs, increasing funding for alternative vaccine platforms, initial clinical validation studies.
The edible vaccine market size is expected to see strong growth in the next few years. It will grow to $14.54 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing demand for needle-free vaccination solutions, rising investments in edible vaccine clinical trials, expansion of livestock immunization programs, growing focus on global vaccine accessibility, advancements in regulatory approval pathways. Major trends in the forecast period include advancements in plant-based vaccine expression systems, growing focus on oral vaccine delivery methods, expansion of low-cost vaccine production models, increasing research on heat-stable vaccines, rising collaboration between biotech and agricultural sectors.
The rising prevalence of infectious diseases is expected to drive the growth of the edible vaccine market going forward. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that enter the body and multiply. The increasing incidence of these diseases is largely attributed to factors including globalization, climate change, urbanization, and growing antibiotic resistance, all of which contribute to the spread and emergence of new pathogens. Edible vaccines are used to address infectious diseases by triggering immune responses through the consumption of genetically modified foods that express antigens, providing a cost-effective and needle-free approach to immunization. For example, in March 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, reflecting a rise of 1,295 cases. Additionally, the incidence rate per 100,000 people increased from 2.5 in 2022 to 2.9 in 2023. Therefore, the growing prevalence of infectious diseases is fueling the expansion of the edible vaccine market.
The increase in research and development funding is also expected to propel the growth of the edible vaccine market going forward. Research and development funding refers to financial investments dedicated to systematic research and experimental activities aimed at generating new knowledge and developing innovative technologies or products. Governments worldwide are increasing their investment in research and development as they recognize the importance of scientific innovation in tackling global health challenges and maintaining competitiveness in the biotechnology sector. Higher levels of research funding enable researchers and pharmaceutical companies to advance edible vaccine development, conduct clinical trials, and scale up production processes. For instance, in December 2024, according to the Office for National Statistics, a UK-based government agency, businesses in the UK spent $64.73 billion (£50.0 billion) on research and development in 2023, representing a 2.9% increase, or $1.83 billion (£1.4 billion), compared with 2022. Therefore, rising investment in research and development is contributing to the growth of the edible vaccine market.
Companies operating in the edible vaccine market are increasingly focused on developing innovative solutions, such as oral cholera vaccines, to address the global burden of cholera. Oral cholera vaccines are administered by mouth and are designed to prevent cholera, a severe diarrheal disease caused by the bacterium Vibrio cholerae. For example, in August 2024, Bharat Biotech International Limited, an India-based biotechnology company, introduced Hillchol, an oral cholera vaccine with several distinctive features. This live-attenuated vaccine stimulates both systemic and mucosal immune responses, offering protection against cholera. Hillchol is notable for its ease of administration and its ability to be stored without refrigeration, making it particularly suitable for deployment in resource-limited regions. In addition, it provides long-lasting immunity with a single dose.
Major companies operating in the edible vaccine market are Medicago Inc., Vaxart Inc., Vaxiion Therapeutics Inc., Mymetics Corporation, Profectus BioSciences Inc., GreenLight Biosciences Inc., Akston Biosciences Corporation, Icon Genetics GmbH, iBio Inc., Kentucky BioProcessing Inc., Fraunhofer USA Center for Molecular Biotechnology, Nomad Bioscience GmbH, Baiya Phytopharm Company Limited, Dow AgroSciences LLC, GenCure Biomanufacturing, Transgene SA, PlantForm Corporation, BioBetter Ltd., Moolec Science SA, Agrenvec SL
North America was the largest region in the edible vaccine market in 2025. The regions covered in the edible vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the edible vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The edible vaccine market consists of sales of plant-based edible vaccines, animal-based edible vaccines, algae-based edible vaccines, and yeast-based edible vaccines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Edible Vaccine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses edible vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for edible vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The edible vaccine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Vaccine Type: Subunit Vaccines; Virus-Like Particle VLP Vaccines; Plant-Expressed Antigen Vaccines; Recombinant Protein Vaccines; Other Edible Vaccine Types
2) By Source: Fruits; Vegetables; Cereal Grains; Legumes; Other Edible Plants
3) By Route of Administration: Oral Fresh Plant Consumption; Oral Processed Edible Form Feed; Sublingual And Buccal Edible Extract-Based
4) By Distribution Model: Public Health And Immunization Programs; Veterinary And Animal Health Programs; Direct Farm-Level Administration; Research And Academic Institutions
5) By Application: Human Immunization; Veterinary Vaccines; Livestock; Poultry; Aquaculture Vaccines; Other Applications
6) By End User: Adults; Pediatrics; Animals
Subsegments:
1) By Subunit Vaccines: Protein Subunit Vaccines; Polysaccharide Subunit Vaccines; Conjugated Subunit Vaccines
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
4.1.5 Fintech, Blockchain, Regtech & Digital Finance
4.2. Major Trends
4.2.1 Advancements In Plant-Based Vaccine Expression Systems
4.2.2 Growing Focus On Oral Vaccine Delivery Methods
4.2.3 Expansion Of Low-Cost Vaccine Production Models
4.2.4 Increasing Research On Heat-Stable Vaccines
4.2.5 Rising Collaboration Between Biotech And Agricultural Sectors
5. Edible Vaccine Market Analysis Of End Use Industries
5.1 Biotechnology Companies
5.2 Pharmaceutical Manufacturers
5.3 Research Institutes
5.4 Public Health Organizations
5.5 Veterinary Healthcare Providers
6. Edible Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Edible Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Edible Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Edible Vaccine Market Size, Comparisons And Growth Rate Analysis
7.3. Global Edible Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Edible Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Edible Vaccine Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Edible Vaccine Market Segmentation
9.1. Global Edible Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Subunit Vaccines, Virus-Like Particle VLP Vaccines, Plant-Expressed Antigen Vaccines, Recombinant Protein Vaccines, Other Edible Vaccine Types
9.2. Global Edible Vaccine Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Fruits, Vegetables, Cereal Grains, Legumes, Other Edible Plants
9.3. Global Edible Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral Fresh Plant Consumption, Oral Processed Edible Form Feed, Sublingual And Buccal Edible Extract-Based
9.4. Global Edible Vaccine Market, Segmentation By Distribution Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Public Health And Immunization Programs, Veterinary And Animal Health Programs, Direct Farm-Level Administration, Research And Academic Institutions
9.5. Global Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Human Immunization, Veterinary Vaccines, Livestock, Poultry, Aquaculture Vaccines, Other Applications
9.6. Global Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Adults, Pediatrics, Animals
9.7. Global Edible Vaccine Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Protein Subunit Vaccines, Polysaccharide Subunit Vaccines, Conjugated Subunit Vaccines
9.8. Global Edible Vaccine Market, Sub-Segmentation Of Virus-Like Particle VLP Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.9. Global Edible Vaccine Market, Sub-Segmentation Of Plant-Expressed Antigen Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.10. Global Edible Vaccine Market, Sub-Segmentation Of Recombinant Protein Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.11. Global Edible Vaccine Market, Sub-Segmentation Of Other Edible Vaccine Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10. Edible Vaccine Market Regional And Country Analysis
10.1. Global Edible Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Edible Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Edible Vaccine Market
11.1. Asia-Pacific Edible Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Edible Vaccine Market
12.1. China Edible Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Edible Vaccine Market
13.1. India Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Edible Vaccine Market
14.1. Japan Edible Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Edible Vaccine Market
15.1. Australia Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Edible Vaccine Market
16.1. Indonesia Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Edible Vaccine Market
17.1. South Korea Edible Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Edible Vaccine Market
18.1. Taiwan Edible Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Edible Vaccine Market
19.1. South East Asia Edible Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Edible Vaccine Market
20.1. Western Europe Edible Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Edible Vaccine Market
21.1. UK Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Edible Vaccine Market
22.1. Germany Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Edible Vaccine Market
23.1. France Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Edible Vaccine Market
24.1. Italy Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Edible Vaccine Market
25.1. Spain Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Edible Vaccine Market
26.1. Eastern Europe Edible Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Edible Vaccine Market
27.1. Russia Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Edible Vaccine Market
28.1. North America Edible Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Edible Vaccine Market
29.1. USA Edible Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Edible Vaccine Market
30.1. Canada Edible Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Edible Vaccine Market
31.1. South America Edible Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Edible Vaccine Market
32.1. Brazil Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Edible Vaccine Market
33.1. Middle East Edible Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Edible Vaccine Market
34.1. Africa Edible Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Edible Vaccine Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Edible Vaccine Market Regulatory and Investment Landscape
36. Edible Vaccine Market Competitive Landscape And Company Profiles
36.1. Edible Vaccine Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Edible Vaccine Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Edible Vaccine Market Company Profiles
36.3.1. Medicago Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Vaxart Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Vaxiion Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Mymetics Corporation Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Profectus BioSciences Inc. Overview, Products and Services, Strategy and Financial Analysis
37. Edible Vaccine Market Other Major And Innovative Companies
GreenLight Biosciences Inc., Akston Biosciences Corporation, Icon Genetics GmbH, iBio Inc., Kentucky BioProcessing Inc., Fraunhofer USA Center for Molecular Biotechnology, Nomad Bioscience GmbH, Baiya Phytopharm Company Limited, Dow AgroSciences LLC, GenCure Biomanufacturing, Transgene SA, PlantForm Corporation, BioBetter Ltd., Moolec Science SA, Agrenvec SL
38. Global Edible Vaccine Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Edible Vaccine Market
40. Edible Vaccine Market High Potential Countries, Segments and Strategies
40.1 Edible Vaccine Market In 2030 - Countries Offering Most New Opportunities
40.2 Edible Vaccine Market In 2030 - Segments Offering Most New Opportunities
40.3 Edible Vaccine Market In 2030 - Growth Strategies
